Clinical Trial

Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients

Study acronym: DETECT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-11-08; most recent amendment 2025-09-15.
Status change: Not Yet Recruiting → Recruiting 2024-06-25
Trial Details
NCT Number NCT05112705
Lead Sponsor King Abdullah International Medical Research Center
Conditions Deep Vein Thrombosis, Pulmonary Embolism
Enrollment 1,800 participants
Start Date 2023-03-21
Primary Completion 2026-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-19